Alpha-synuclein and tau: teammates in neurodegeneration?
about
Putative Role of Red Wine Polyphenols against Brain Pathology in Alzheimer's and Parkinson's DiseaseProteomics in Traditional Chinese Medicine with an Emphasis on Alzheimer's DiseaseKey Targets for Multi-Target Ligands Designed to Combat NeurodegenerationRoles of tau protein in health and disease.TDP-43 suppresses tau expression via promoting its mRNA instability.Synuclein impairs trafficking and signaling of BDNF in a mouse model of Parkinson's disease.Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson's diseaseProgression of Behavioral and CNS Deficits in a Viable Murine Model of Chronic Neuronopathic Gaucher Disease.Role for the microtubule-associated protein tau variant p.A152T in risk of α-synucleinopathies.Immunotherapeutic Approaches Targeting Amyloid-β, α-Synuclein, and Tau for the Treatment of Neurodegenerative Disorders.Parkinson disease and progressive supranuclear palsy: protein expression in skin.Precision Modulation of Neurodegenerative Disease-Related Gene Expression in Human iPSC-Derived Neurons.Widespread transneuronal propagation of α-synucleinopathy triggered in olfactory bulb mimics prodromal Parkinson's diseaseTRIM28 regulates the nuclear accumulation and toxicity of both alpha-synuclein and tau.Untangling a role for tau in synucleinopathies.Review: Spreading the word: precise animal models and validated methods are vital when evaluating prion-like behaviour of alpha-synuclein.From Reproducibility to Translation in Neurodegenerative Disease.Interactions of pathological proteins in neurodegenerative diseases.A Brief Overview of Tauopathy: Causes, Consequences, and Therapeutic Strategies.The role of Ca2+ signaling in Parkinson's disease.Neonatal AAV delivery of alpha-synuclein induces pathology in the adult mouse brain.Copy number variation analysis of the 17q21.31 region and its role in neurodegenerative diseases.Parkinson disease polygenic risk score is associated with Parkinson disease status and age at onset but not with alpha-synuclein cerebrospinal fluid levels.c-Abl and Parkinson's Disease: Mechanisms and Therapeutic Potential.Elevated Serum α-Synuclein Autoantibodies in Patients with Parkinson’s Disease Relative to Alzheimer’s Disease and Controls.Elevated Serum α-Synuclein Autoantibodies in Patients with Parkinson's Disease Relative to Alzheimer's Disease and Controls.Molecular mechanisms of the co-deposition of multiple pathological proteins in neurodegenerative diseases.Role of the microtubule-associated TPPP/p25 in Parkinson's and related diseases and its therapeutic potential.MAPT haplotype H1G is associated with increased risk of dementia with Lewy bodies.α-Synuclein Dimers Impair Vesicle Fission during Clathrin-Mediated Synaptic Vesicle Recycling.CXCR4 involvement in neurodegenerative diseases.Mitochondrial Molecular Abnormalities Revealed by Proteomic Analysis of Hippocampal Organelles of Mice Triple Transgenic for Alzheimer Disease.Plasma Biomarkers Differentiate Parkinson's Disease From Atypical Parkinsonism Syndromes.Protein Co-Aggregation Related to Amyloids: Methods of Investigation, Diversity, and Classification
P2860
Q26738450-2EB0535B-99EA-43F2-9EFB-80D66DAAD5C4Q26777933-DF703AEF-ADCB-4554-A9BA-3B8ABE77C5DFQ28077589-8B234412-D89E-4054-A0B1-24A5AB4444E2Q33559303-A6CC1AFD-BA33-4B2B-8BD7-69EF56DD3C9DQ33740999-5A76FBA9-22AC-491F-AF44-FAF10F73EF50Q33819127-C961CCB3-2FF8-4595-BE3A-1DB3B29C6955Q35897340-F55B636C-8B77-47D9-9E82-A667A038F6D4Q36123828-EDAB9075-6B2A-488D-8EF2-DB3E1A388FF1Q36300071-AA5FAE99-9F58-4FDB-BD9A-D319C96483C9Q36484413-D75A8914-F833-486F-8044-EA045202FC9FQ36639646-93C2522F-7A33-4C82-933B-FE83631E2C6BQ37035851-3DA27950-7747-48EF-9429-BF417482F1D4Q37197984-DE8E21C5-4E8D-4FD6-A3AD-BACB1C7445ECQ37407659-AD288B50-664B-4AD5-B16C-8CA010725EA5Q37451916-392D5981-B7A9-4D9E-B315-DEDAFC5F9531Q38669105-F55FE7E4-1F0F-408B-9161-BCEC6A51ADD5Q38819341-224A8C33-B967-4490-BC32-502AD462D062Q39236779-117F33D3-D9BB-412A-9F45-E380C7CE5405Q39270980-31006021-E1C0-4F7E-B028-2658C7F97BADQ39281423-1ADFEF18-ECCA-48B3-9D49-90E4FE65A506Q40147786-BFFDE17D-5895-436C-8DE1-F61378E484B8Q40321087-024E2245-48AF-430B-B39A-15762437E949Q45915163-2C45A188-B04F-44A1-AA29-AEB96899CAAFQ47124745-7C38109D-0669-4A28-A12B-F5918BD18D0AQ47194996-51F1E02F-CBAD-4279-928F-CEDB7AD58F06Q47221798-1DEA6E06-D2DF-48A9-A8B7-EFF65503517EQ47742824-5E875754-5FD7-4A2E-94CA-4E426B2AEBCDQ48274208-AEB9BC4C-B222-4D3A-97CE-49E1C394B776Q48684459-73B19E20-DDD2-4C35-ACDA-1D5ECB30920FQ49330024-E68F4D61-B3EC-4BD3-9733-BEB96B512EE1Q52317581-DEF9DB20-7718-47CF-986A-B6DA2B90D10CQ53396803-BC09B6FB-E298-4177-9763-C2AD61B8F351Q55110559-C6630F73-EAE4-4254-A63D-ED3968F4B598Q58800414-E80E4BA0-1190-4D34-8321-0B547C684EF0
P2860
Alpha-synuclein and tau: teammates in neurodegeneration?
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Alpha-synuclein and tau: teammates in neurodegeneration?
@ast
Alpha-synuclein and tau: teammates in neurodegeneration?
@en
Alpha-synuclein and tau: teammates in neurodegeneration?
@nl
type
label
Alpha-synuclein and tau: teammates in neurodegeneration?
@ast
Alpha-synuclein and tau: teammates in neurodegeneration?
@en
Alpha-synuclein and tau: teammates in neurodegeneration?
@nl
prefLabel
Alpha-synuclein and tau: teammates in neurodegeneration?
@ast
Alpha-synuclein and tau: teammates in neurodegeneration?
@en
Alpha-synuclein and tau: teammates in neurodegeneration?
@nl
P2093
P2860
P921
P3181
P356
P1476
Alpha-synuclein and tau: teammates in neurodegeneration?
@en
P2093
Daryl R Jones
Elisabeth L Moussaud-Lamodière
Marion Delenclos
Pamela J McLean
P2860
P2888
P3181
P356
10.1186/1750-1326-9-43
P407
P5008
P577
2014-10-29T00:00:00Z
P5875
P6179
1049166689